Nanjing Hicin Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 117.2 million compared to CNY 150.61 million a year ago. Revenue was CNY 117.2 million compared to CNY 150.61 million a year ago.

Net income was CNY 12.21 million compared to CNY 12.62 million a year ago. Basic earnings per share from continuing operations was CNY 0.1018 compared to CNY 0.1052 a year ago. Diluted earnings per share from continuing operations was CNY 0.1018 compared to CNY 0.1052 a year ago.